Soricimed Biopharma Inc.

Dedicated to developing effective and novel targeted treatments for cancer.

Founded 2005 Canada

Canada 12 employees Grant Total: $3.26M Biopharma, Biotechnology +1

Soricimed Biopharma Inc. is a privately-held, clinical stage company dedicated to developing effective and novel targeted treatments for cancer. Since the discovery of a unique protein found in the venomous saliva of the northern short-tailed shrew in 2005, the company is committed to developing effective, highly targeted delivery peptides and powerful therapeutics for several types of solid tumour cancers, making an impact on those living with often devastating conditions. Soricimed operates in the Biopharma, Biotechnology, and Health Care industries and is headquartered in Canada. Their most recent $200.00K grant investment was received on 12 July 2022 from the New Brunswick Innovation Foundation. The company's slogan "Dedicated to developing effective and novel targeted treatments for cancer" reflects its focus on creating innovative solutions for cancer treatment. Soricimed's innovative approach, commitment to developing highly targeted treatments, and recent investment from a reputable foundation demonstrate its potential for making significant advancements in cancer therapeutics. With a strong emphasis on leveraging biological discoveries for medical breakthroughs, Soricimed has positioned itself as a promising player in the biopharmaceutical landscape.

Funding Stage	Amount	Investors	Lead Investors	Date
Grant	$200.00K	1	New Brunswick Innovation Foundation	12 Jul 2022
Venture Round	$2.78M	-		31 Jan 2022
Grant	$175.00K	1	New Brunswick Innovation Foundation	01 Jan 2020
Venture Round	Undisclosed	1	New Brunswick Innovation Foundation	01 Jan 2018
Seed Round	$109.00K	-		18 Oct 2011

Funding Stage

Amount

Investors

Lead Investors

Date

Grant

$200.00K

New Brunswick Innovation Foundation

12 Jul 2022

Venture Round

$2.78M

31 Jan 2022

Grant

$175.00K

New Brunswick Innovation Foundation

01 Jan 2020

Venture Round

Undisclosed

New Brunswick Innovation Foundation

01 Jan 2018

Seed Round

$109.00K

18 Oct 2011

FAQ About Soricimed Biopharma Inc.

Dedicated to developing effective and novel targeted treatments for cancer.

Soricimed Biopharma Inc. was founded in 2005.

Soricimed Biopharma Inc. is headquartered in Canada.

Soricimed Biopharma Inc. operates in Biopharma, Biotechnology and Health Care. Its work centres on cancer treatment, targeted therapy, clinical stage company and venomous saliva protein.

Soricimed Biopharma Inc. has approximately 12 employees.

Soricimed Biopharma Inc. has completed 5 funding rounds, raising a total of $3.26M. The latest funding stage is Grant.

Top alternatives and competitors to Soricimed Biopharma Inc. include Prescient Therapeutics, Anchiano Therapeutics, Genus Oncology LLC, Antikor Biopharma Ltd, Arno Therapeutics Inc (ARNI). These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Soricimed Biopharma Inc. and Prescient Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Soricimed Biopharma Inc.

General Information

Discover More

About Soricimed Biopharma Inc.

Funding Rounds & Investors (5)

Soricimed Biopharma Inc. Alternatives & Competitors

FAQ About Soricimed Biopharma Inc.